New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 11, 2012
19:56 EDTHZNPHorizon presents data showing effectiveness of RAYOS
Horizon Pharma announced an additional analysis of data from the pivotal Circadian Administration of Prednisone in Rheumatoid Arthritis-2, CAPRA-2, clinical trial demonstrating that patients with active rheumatoid arthritis (RA) treated with its recently approved RAYOS 5 mg (prednisone) delayed-release tablets had a significant improvement in reduction of fatigue, as determined by the Functional Assessment of Chronic Illness Therapy - Fatigue, FACIT-F, questionnaire. Data were presented during the American College of Rheumatology, ACR/Association of Rheumatology Health Professionals,ARHP, Annual Scientific Meeting in Washington, D.
News For HZNP From The Last 14 Days
Check below for free stories on HZNP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
10:00 EDTHZNPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:43 EDTHZNPHorizon Pharma downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
July 28, 2014
13:03 EDTHZNPHorizon Pharma shares offer 'significant value,' says Stifel
Subscribe for More Information
12:21 EDTHZNPOn The Fly: Midday Wrap
Subscribe for More Information
09:17 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
06:22 EDTHZNPHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information
July 16, 2014
11:28 EDTHZNPHorizon Pharma management to meet with Jefferies
Meetings to be held in San Diego/San Francisco July 23-24 hosted by Jefferies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use